The trademark application LARIXICINA was filed by Unifarco S.p.A., a corporation established under the laws of the Italian Republic (the "Applicant"). The application was published for oppositions on February 21, 2021, and it was registered by office on May 31, 2021 without any oppositions.
The application was filed in Italian (English was selected as the second language).